Eclipsys/Allscripts Merger
On June 9, 2010 Allscripts (Nasdaq: MDRX) and Eclipsys (Nasdaq: ECLP) announced a definitive agreement to merge in an all-stock transaction valued at approximately $1.3 billion.
Under terms of the merger agreement, Eclipsys stockholders will receive 1.2 shares of Allscripts for each share of Eclipsys, a 19 percent premium based on the June 8th closing price.
UBS, Barclays Capital and J.P. Morgan acted as financial advisors to Allscripts on the merger, and Blackstone and William Blair acted as financial advisors to the Audit Committee of Allscripts. Perella Weinberg Partners acted as financial advisor to Eclipsys. Credit Suisse acted as financial advisor to Misys.
The companies expect the merger to close in approximately four to six months.
View Older Stories
View Older Stories
